Glufosfamide

Unknown Manufacturer

Indications

Investigated for use/treatment in pancreatic cancer, solid tumors, breast cancer, colorectal cancer, brain cancer, lung cancer, ovarian cancer, and sarcoma.

Technical identifiers

Chemical Formula: C₁₀H₂₁Cl₂N₂O₇P
CAS Number: 132682-98-5
UNII ID: 1W5N8SZD9A

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

Anti-cancer therapies
US 8318683 B2Applicant: TIDMARSH GEORGEPriority: 2005
US
4 publications
Glufosfamide Combination Therapies for Cancer
US 2013281386 A1Applicant: ANTHONY FORREST HPriority: 2012
CN
US
2 publications
GLUFOSFAMIDE COMBINATION THERAPY
- US 2010104549 A1
  Applicant: THRESHOLD PHARMACEUTICALS INCPriority: 2008
  US
  2 publications
- US 2011182909 A1
  Applicant: THRESHOLD PHARMACEUTICALS INCPriority: 2005
  US
Glucose phosphonic amide crystals and preparation process and use thereof
CN 1827629 AApplicant: HENAN TIANYUAN KANGZE PHARMACEPriority: 2006
CN
Unit Dose Form of Glufosfamide
US 2009270339 A1Applicant: LI MIKEPriority: 2007
US
Administration of Glufosfamide For The Treatment of Cancer
US 2011207680 A1Applicant: CURD JOHN GPriority: 2009
US
Anticancer pharmaceutical application of glufosfamide
CN 109833324 AApplicant: ASCENTAWITS PHARMACEUTICALS LTDPriority: 2017
CN
Medical application of glufosfamide to resisting cancer
CN 110269862 AApplicant: ASCENTAWITS PHARMACEUTICALS LTDPriority: 2018
CN

Drugs

Glufosfamide

Indications

Patents

GLUFOSFAMIDE COMBINATION THERAPY